Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hyaluronic acid + calcium hydroxyapatite
- Development stage
- Unknown
- Lead developer
- Allergan Aesthetics
- Administration
- Intradermal
01
Overview
Hyaluronic acid + calcium hydroxyapatite is a hybrid dermal filler that combines the immediate volumizing effects of cross-linked hyaluronic acid with the long-term biostimulatory properties of calcium hydroxyapatite microspheres. Developed by Allergan Aesthetics (an AbbVie company) under the brand name HArmonyCa (originally developed by Luminera), this injectable formulation is designed for facial soft tissue augmentation, particularly in the mid and lower face. The hyaluronic acid component provides instant lift and volume through mechanical support, while the calcium hydroxyapatite microspheres stimulate fibroblasts to promote neocollagenesis, leading to sustained improvements in skin quality and structural integrity. A version containing lidocaine (HArmonyCa-L) is also available to improve patient comfort during the procedure.
- Brand names
- HArmonyCaHArmonyCa-LRveiling HA-CaHA
- Other names
- HA-CaHA fillerhyaluronic acid and calcium hydroxyapatite hybrid filler
Beyond the preview
Go deeper on hyaluronic acid + calcium hydroxyapatite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hyaluronic acid + calcium hydroxyapatite.